Blumberg Scott sold $25K of CBLL
Blumberg Scott (Chief Financial Officer) sold 1,387 shares of Ceribell, Inc. (CBLL) at $18.00 on 2026-05-21.
How this was made
The 30-second read
Why it matters
Insider selling disclosures can influence short-term sentiment, but without accompanying operational updates they rarely drive durable repricing.
Market read
A modest insider sale was disclosed; treat as low-signal unless it clusters with other negative catalysts.
What to watch
No 10b5-1 plan is cited, but Form 4 details alone cannot establish intent; consider follow-on insider activity and upcoming clinical/financial milestones.
Background
The article is an SEC Form 4 insider transaction disclosure for Ceribell, Inc.
Ticker impact
Ceribell CFO Blumberg Scott filed an open-market sale of 1,387 CBLL shares for about $25K, disclosed via SEC Form 4.
Low likelihood of a sustained price move; any reaction is likely brief and sentiment-driven.
The filing is an insider transaction with a relatively small dollar value and no 10b5-1 plan indicated, but it does not include operational or financial news.
Market effects
Limited read-across to diagnostics/biotech; insider sales are common and typically not sector-moving without additional company-specific catalysts.
None indicated; this is a US-listed company insider disclosure.
None indicated; no international deal/regulatory action mentioned.
Counterpoint
The sale could be routine liquidity/portfolio rebalancing rather than a bearish signal, especially for a small value transaction.
Key entities
- issuerCeribell, Inc.
CBLL; CFO Blumberg Scott reported an open-market sale of 1,387 shares at $18.00 on 2026-05-21.
- insiderBlumberg Scott
CFO of Ceribell; sold $24,966 of CBLL shares; holdings after sale: 147,683 shares.